NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Psoriasis Vulgaris
Date of first enrollment	03/09/2009
Target sample size	240
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Tacalcitol ointment(20mcg/g) INN of investigational material : Tacalcitol monohydrate (INNM) Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : Topical application control material(s) Generic name etc : Tacalcitol ointment(2mcg/g) INN of investigational material : Tacalcitol monohydrate (INNM) Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : Topical application

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	<= 65age old
Gender	Both
Include criteria	Psoriasis vulgaris
Exclude criteria